Robert E Brady, Jessica K Salwen-Deremer, Natalie C Tunnell, Michael W Winter
{"title":"Understanding Medication Nonadherence in Crohn's Disease Patients: A Qualitative Evaluation.","authors":"Robert E Brady, Jessica K Salwen-Deremer, Natalie C Tunnell, Michael W Winter","doi":"10.1093/ibd/izad296","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Immune-modifying medications are widely available and recognized as valuable by most gastroenterologists. However, approximately 40% of patients with Crohn's disease (CD) do not comply with regimens using these medications, resulting in complications, hospitalization, and surgeries. We sought to identify factors that motivate adherence or nonadherence with medication recommendations for CD.</p><p><strong>Methods: </strong>We conducted qualitative interviews with patients living with CD who were identified as adherent or nonadherent to immune-modifying medication recommendations by their treating gastroenterologist. Semistructured interview guides were developed based on an established framework for understanding health behaviors. We conducted content analysis of the resulting qualitative data using an inductive-deductive approach to identify emergent themes that influence medication decision-making.</p><p><strong>Results: </strong>Twenty-five patients with CD completed interviews for this study. Interviews were independently coded and analyzed for thematic content. Two broad domains emerged comprising (1) themes reflected in the Theoretical Domains Framework and (2) novel themes specific to medication decision-making in CD. Adherent patients conveyed a sense of trust in science and healthcare provider expertise, while nonadherent patients were more likely to express beliefs in their ability to self-manage CD, concern about risks associated with medication, and a general ambivalence to treatment.</p><p><strong>Conclusions: </strong>There are clear cognitive, behavioral, and relational factors that guide patients' medication-related decision-making. Several of the factors share features of other behavioral change and decision-making processes, while others are specific to the experience of patients with CD. A fuller understanding of these factors is essential to developing effective behavioral interventions to improve adherence to evidence-based treatment recommendations.</p>","PeriodicalId":13623,"journal":{"name":"Inflammatory Bowel Diseases","volume":" ","pages":"2046-2056"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammatory Bowel Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ibd/izad296","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Immune-modifying medications are widely available and recognized as valuable by most gastroenterologists. However, approximately 40% of patients with Crohn's disease (CD) do not comply with regimens using these medications, resulting in complications, hospitalization, and surgeries. We sought to identify factors that motivate adherence or nonadherence with medication recommendations for CD.
Methods: We conducted qualitative interviews with patients living with CD who were identified as adherent or nonadherent to immune-modifying medication recommendations by their treating gastroenterologist. Semistructured interview guides were developed based on an established framework for understanding health behaviors. We conducted content analysis of the resulting qualitative data using an inductive-deductive approach to identify emergent themes that influence medication decision-making.
Results: Twenty-five patients with CD completed interviews for this study. Interviews were independently coded and analyzed for thematic content. Two broad domains emerged comprising (1) themes reflected in the Theoretical Domains Framework and (2) novel themes specific to medication decision-making in CD. Adherent patients conveyed a sense of trust in science and healthcare provider expertise, while nonadherent patients were more likely to express beliefs in their ability to self-manage CD, concern about risks associated with medication, and a general ambivalence to treatment.
Conclusions: There are clear cognitive, behavioral, and relational factors that guide patients' medication-related decision-making. Several of the factors share features of other behavioral change and decision-making processes, while others are specific to the experience of patients with CD. A fuller understanding of these factors is essential to developing effective behavioral interventions to improve adherence to evidence-based treatment recommendations.
背景:免疫调节药物已被广泛使用,并被大多数胃肠病学家认为是有价值的药物。然而,约有 40% 的克罗恩病(CD)患者不遵守使用这些药物的治疗方案,导致并发症、住院和手术。我们试图找出促使克罗恩病患者遵守或不遵守用药建议的因素:我们对被消化内科医生认定为坚持或不坚持免疫调节药物治疗建议的 CD 患者进行了定性访谈。我们根据了解健康行为的既定框架制定了半结构化访谈指南。我们采用归纳-演绎法对所得定性数据进行了内容分析,以确定影响用药决策的新出现的主题:25 名 CD 患者完成了本研究的访谈。我们对访谈内容进行了独立编码和主题分析。访谈中出现了两大领域,包括:(1)理论领域框架中反映的主题;(2)CD 患者用药决策中特有的新主题。坚持用药的患者表达了对科学和医疗服务提供者专业知识的信任感,而不坚持用药的患者则更倾向于表达对自我管理 CD 能力的信念、对药物治疗相关风险的担忧以及对治疗的普遍矛盾心理:有明显的认知、行为和关系因素引导患者做出与用药相关的决策。其中一些因素与其他行为改变和决策过程有相同之处,而其他因素则是 CD 患者的特殊经历。更全面地了解这些因素对于制定有效的行为干预措施以提高循证治疗建议的依从性至关重要。
期刊介绍:
Inflammatory Bowel Diseases® supports the mission of the Crohn''s & Colitis Foundation by bringing the most impactful and cutting edge clinical topics and research findings related to inflammatory bowel diseases to clinicians and researchers working in IBD and related fields. The Journal is committed to publishing on innovative topics that influence the future of clinical care, treatment, and research.